Market Overview:
The global pharmaceutical marijuana (MMJ) market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the legalization of cannabis for medical purposes and the growing demand for MMJ products for various applications such as cancer, arthritis, migraine, epilepsy, and others. The THC-dominant segment is expected to hold the largest share of the global pharmaceutical marijuana (MMJ) market in 2018. However, the CBD-dominant segment is projected to grow at a higher CAGR during the forecast period from 2018 to 2030. This can be attributed to its growing popularity owing to its therapeutic benefits such as reducing inflammation and pain relief without causing psychoactive effects.
 Industry Outlook.svg)
Product Definition:
Pharmaceutical marijuana is a term used to describe the use of cannabis or cannabinoids as a pharmaceutical drug. Pharmaceutical marijuana is important because it can be used to treat conditions such as chronic pain, multiple sclerosis, and glaucoma.
THC-dominant:
In the last few years, cannabis has been legalized in many countries. One of the key reasons for its legalization is to generate tax revenues from its cultivation and sale. Another reason is that it helps reduce crime rates as it’s used for medical and recreational purposes. However, most countries don’t have a large population base; hence they can only afford to buy small quantities which are expensive due to high import duties & taxes levied on them by governments of respective countries.
CBD-dominant:
Cannabidiol (CBD) is one of the cannabinoids present in the cannabis plant, which has positive effects on users. CBD-dominant products are gaining popularity among consumers looking for alternatives that provide health benefits without intoxication.
Application Insights:
On the basis of application, the global pharmaceutical marijuana market has been segmented into cancer, arthritis, migraine, epilepsy and other neurological conditions, diabetes management, pain management other than arthritis and migraines (other), smoking cessation programs (nicotine replacement therapy), and others.
Cancer was estimated to be the largest revenue generating segment in 2017 owing to increasing incidence of cancer across all age groups globally. Increasing research & development activities for developing new products for treating various types of cancers is also expected to contribute towards growth during forecast period.
The use of cannabis or its derivatives in treatment methods for epilepsy is still considered as an experimental approach; however their usage in managing epileptic seizures has been legalized throughout many countries including Canada Australia New Zealand under strict guidelines from health authorities.
Regional Analysis:
North America dominated the global MMJ market in 2017. The region is expected to maintain its position during the forecast period owing to presence of large number of MMJ companies and high patient awareness levels coupled with favorable government initiatives. For instance, in 2014, Canada legalized medical marijuana under a new set of regulations that makes it easier for patients to obtain cannabis products by registering them with Health Canada instead of obtaining a prescription from their doctor. In addition, increasing use by military services and recommendation by U.
Asia Pacific is expected witness lucrative growth during the forecast period owing to rising demand from countries such as Australia, China and Japan among others which constitute majority of Asia Pacific population base thus making it one of fastest growing regions globally over the next eight years (2030).
Growth Factors:
- Increasing legalization of marijuana for medical purposes across the globe.
- Growing research on therapeutic benefits of marijuana for various diseases and conditions.
- Rising number of cannabis dispensaries and pharmacies offering MMJ products.
- Proliferation of cannabis-based drugs and therapies in the pharmaceutical market.
- Increasing demand for alternative pain management therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Marijuana (MMJ) Market Research Report
By Type
THC-dominant, CBD-dominant, Balanced THC & CBD
By Application
Cancer, Arthritis, Migraine, Epilepsy, Others
By Companies
Canopy Growth Corporation, GW Pharmaceuticals, plc, Aurora Cannabis, Inc., Aphria, Inc., MedReleaf Corporation, Insys Therapeutics, Inc., CanniMed Therapeutics, Inc., Cara Therapeutics, Inc., United Cannabis Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Marijuana (MMJ) Market Report Segments:
The global Pharmaceutical Marijuana (MMJ) market is segmented on the basis of:
Types
THC-dominant, CBD-dominant, Balanced THC & CBD
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Arthritis, Migraine, Epilepsy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Canopy Growth Corporation
- GW Pharmaceuticals, plc
- Aurora Cannabis, Inc.
- Aphria, Inc.
- MedReleaf Corporation
- Insys Therapeutics, Inc.
- CanniMed Therapeutics, Inc.
- Cara Therapeutics, Inc.
- United Cannabis Corporation
 Market Overview.svg)
Highlights of The Pharmaceutical Marijuana (MMJ) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- THC-dominant
- CBD-dominant
- Balanced THC & CBD
- By Application:
- Cancer
- Arthritis
- Migraine
- Epilepsy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Marijuana (MMJ) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical marijuana is a term used to describe products that contain cannabinoids, which are the active ingredients in cannabis. These products can be prescribed by doctors to help treat specific medical conditions.
Some of the major players in the pharmaceutical marijuana (mmj) market are Canopy Growth Corporation, GW Pharmaceuticals, plc, Aurora Cannabis, Inc., Aphria, Inc., MedReleaf Corporation, Insys Therapeutics, Inc., CanniMed Therapeutics, Inc., Cara Therapeutics, Inc., United Cannabis Corporation.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical Marijuana (MMJ) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmaceutical Marijuana (MMJ) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmaceutical Marijuana (MMJ) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmaceutical Marijuana (MMJ) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmaceutical Marijuana (MMJ) Market Size & Forecast, 2018-2028
4.5.1 Pharmaceutical Marijuana (MMJ) Market Size and Y-o-Y Growth
4.5.2 Pharmaceutical Marijuana (MMJ) Market Absolute $ Opportunity
Chapter 5 Global Pharmaceutical Marijuana (MMJ) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pharmaceutical Marijuana (MMJ) Market Size Forecast by Type
5.2.1 THC-dominant
5.2.2 CBD-dominant
5.2.3 Balanced THC & CBD
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pharmaceutical Marijuana (MMJ) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pharmaceutical Marijuana (MMJ) Market Size Forecast by Applications
6.2.1 Cancer
6.2.2 Arthritis
6.2.3 Migraine
6.2.4 Epilepsy
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical Marijuana (MMJ) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical Marijuana (MMJ) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pharmaceutical Marijuana (MMJ) Analysis and Forecast
9.1 Introduction
9.2 North America Pharmaceutical Marijuana (MMJ) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pharmaceutical Marijuana (MMJ) Market Size Forecast by Type
9.6.1 THC-dominant
9.6.2 CBD-dominant
9.6.3 Balanced THC & CBD
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pharmaceutical Marijuana (MMJ) Market Size Forecast by Applications
9.10.1 Cancer
9.10.2 Arthritis
9.10.3 Migraine
9.10.4 Epilepsy
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pharmaceutical Marijuana (MMJ) Analysis and Forecast
10.1 Introduction
10.2 Europe Pharmaceutical Marijuana (MMJ) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pharmaceutical Marijuana (MMJ) Market Size Forecast by Type
10.6.1 THC-dominant
10.6.2 CBD-dominant
10.6.3 Balanced THC & CBD
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pharmaceutical Marijuana (MMJ) Market Size Forecast by Applications
10.10.1 Cancer
10.10.2 Arthritis
10.10.3 Migraine
10.10.4 Epilepsy
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pharmaceutical Marijuana (MMJ) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pharmaceutical Marijuana (MMJ) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pharmaceutical Marijuana (MMJ) Market Size Forecast by Type
11.6.1 THC-dominant
11.6.2 CBD-dominant
11.6.3 Balanced THC & CBD
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pharmaceutical Marijuana (MMJ) Market Size Forecast by Applications
11.10.1 Cancer
11.10.2 Arthritis
11.10.3 Migraine
11.10.4 Epilepsy
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pharmaceutical Marijuana (MMJ) Analysis and Forecast
12.1 Introduction
12.2 Latin America Pharmaceutical Marijuana (MMJ) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pharmaceutical Marijuana (MMJ) Market Size Forecast by Type
12.6.1 THC-dominant
12.6.2 CBD-dominant
12.6.3 Balanced THC & CBD
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pharmaceutical Marijuana (MMJ) Market Size Forecast by Applications
12.10.1 Cancer
12.10.2 Arthritis
12.10.3 Migraine
12.10.4 Epilepsy
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pharmaceutical Marijuana (MMJ) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pharmaceutical Marijuana (MMJ) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pharmaceutical Marijuana (MMJ) Market Size Forecast by Type
13.6.1 THC-dominant
13.6.2 CBD-dominant
13.6.3 Balanced THC & CBD
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pharmaceutical Marijuana (MMJ) Market Size Forecast by Applications
13.10.1 Cancer
13.10.2 Arthritis
13.10.3 Migraine
13.10.4 Epilepsy
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical Marijuana (MMJ) Market: Competitive Dashboard
14.2 Global Pharmaceutical Marijuana (MMJ) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Canopy Growth Corporation
14.3.2 GW Pharmaceuticals, plc
14.3.3 Aurora Cannabis, Inc.
14.3.4 Aphria, Inc.
14.3.5 MedReleaf Corporation
14.3.6 Insys Therapeutics, Inc.
14.3.7 CanniMed Therapeutics, Inc.
14.3.8 Cara Therapeutics, Inc.
14.3.9 United Cannabis Corporation
